• +86-0635-6175299
  • li_ye@inyelchem.com
  • Company Details

 Shandong Haohong Biotechnology Co., Ltd.

All
  • All
  • Title
All
  • All
  • Title
HomeProductsAnti-cancer DrugPomalidomide Intermediate
PRODUCT CATEGORIES

Pomalidomide Intermediate

(Total 2 Products)
Pomalidomide Intermediate Cas 19171-18-7

Unit PriceUSD 1 / Kilogram

Min.Order Unit Price
1 Kilogram USD 1 / Kilogram

Brand: HAOHONG

Packaging: PE BAG+Aluminum foil bag+FIBRE DRUM

Supply Ability: 30MT/MONTH

Product Name: 2-(2,6-dioxopiperidin-3-yl)-4-nitroisoindole-1,3-dione; 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-nitro-isoindoline; 2-(2,6-dioxo-piperidin-3-yl)-4-nitro-isoindole-1,3-dione; 3-(1',3'-Dioxo-4'-nitroisoindolinyl-2')-2,6-dioxopiperidine;...
Pomalidomide Intermediate Cas 641-70-3

Unit PriceUSD 1 / Kilogram

Min.Order Unit Price
1 Kilogram USD 1 / Kilogram

Brand: HAOHONG

Packaging: PE BAG+Aluminum foil bag+FIBRE DRUM

Supply Ability: 30MT/MONTH

Product Name: 3-Nitrophthalic anhydride; 1,3-Isobenzofurandione,4-nitro-; 1,3-Isobenzofurandione,4-nitro-; 3-Isobenzofurandione,4-nitro-1; NSC4134;3-Nitrophthalicanhydride,synthesisgrade;...
Home > Products > Anti-cancer Drug > Pomalidomide Intermediate

China Pomalidomide Intermediate Suppliers

Pomalidomide is an orally bioavailable derivative of thalidomide with potential immunomodulating, antiangiogenic and antineoplastic activities. Although its exact mechanism of action has yet to be fully elucidated, pomalidomide appears to inhibit TNF-alpha production, enhance the activity of T cells and natural killer (NK) cells and enhance antibody-dependent cellular cytotoxicity (ADCC). In addition, pomalidomide may inhibit tumor angiogenesis, promote cell cycle arrest in susceptible tumor cell populations, and stimulate erythropoeisis.

Pomalidomide is an immunomodulatory and antineoplastic agent that is used in the therapy of multiple myeloma. Pomalidomide, like the structurally related agents thalidomide and lenalidomide, is associated with a low rate of serum aminotransferase elevations during therapy and has been implicated in causing rare instances of clinically apparent liver injury which can be severe.

Pomalidomide Intermediate Cas 641-70-3,Pomalidomide Intermediate Cas 19171-18-7,Pomalidomide API Cas 19171-19-8

Home

Product

Whatsapp

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send